Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Cash from Investing Activities: 2010-2013

Historic Cash from Investing Activities for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Mar 2013 value amounting to -$116,000.

  • Sonoma Pharmaceuticals' Cash from Investing Activities rose 14.07% to -$116,000 in Q1 2013 from the same period last year, while for Mar 2013 it was -$370,000, marking a year-over-year decrease of 2.78%. This contributed to the annual value of -$80,000 for FY2025, which is 3900.00% down from last year.
  • Per Sonoma Pharmaceuticals' latest filing, its Cash from Investing Activities stood at -$116,000 for Q1 2013, which was down 136.73% from -$49,000 recorded in Q4 2012.
  • Over the past 5 years, Sonoma Pharmaceuticals' Cash from Investing Activities peaked at -$10,000 during Q4 2010, and registered a low of -$172,000 during Q3 2012.
  • For the 3-year period, Sonoma Pharmaceuticals' Cash from Investing Activities averaged around -$92,333, with its median value being -$96,000 (2011).
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first slumped by 410.00% in 2011, then surged by 57.69% in 2012.
  • Over the past 4 years, Sonoma Pharmaceuticals' Cash from Investing Activities (Quarterly) stood at -$10,000 in 2010, then tumbled by 410.00% to -$51,000 in 2011, then climbed by 3.92% to -$49,000 in 2012, then grew by 14.07% to -$116,000 in 2013.
  • Its Cash from Investing Activities was -$116,000 in Q1 2013, compared to -$49,000 in Q4 2012 and -$172,000 in Q3 2012.